What to do after avelumab therapy failure in metastatic Merkel cell carcinoma? Chemotherapy as a bridging strategy in cases of significant tumor progression prior to off-label immunotherapy with ipilimumab and nivolumab.

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Bavencio (avelumab) - EMD Serono

https://programme.conventus.de/ado-2026/program/program-points/1dd03fec-f60d-4695-af60-4447f34c0c5a

Dr. Jan Hendrik Maiwald; Dr. Jan Hendrik Maiwald; Dr. Mareike Kotzerke; Dr. Magdalena-Sophie Greiner; Prof. Dr. Matthias Goebeler; Dr. Valerie Glutsch; Prof. Ugur Uslu; Dr. Anja Gesierich

Sep 7, 2026